Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This study will investigate the safety, tolerability, and pharmacokinetics of new formulation
of bimatoprost following topical application in patients with alopecia. Two formulations of
bimatoprost will be investigated in Part 1 and a third formulation of bimatoprost will be
investigated in Part 2. Part 2 will begin after Part 1 has completed.